.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Novartis
Federal Trade Commission
Queensland Health
Chubb
US Army
Covington
Johnson and Johnson
Fuji
Fish and Richardson

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201292

« Back to Dashboard
NDA 201292 describes GILOTRIF, which is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the GILOTRIF profile page.

The generic ingredient in GILOTRIF is afatinib dimaleate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the afatinib dimaleate profile page.

Summary for NDA: 201292

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Pharmacology for NDA: 201292

Mechanism of ActionProtein Kinase Inhibitors

Suppliers and Packaging for NDA: 201292

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GILOTRIF
afatinib dimaleate
TABLET;ORAL 201292 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0137 0597-0137-30 1 BOTTLE in 1 CARTON (0597-0137-30) > 30 TABLET, FILM COATED in 1 BOTTLE
GILOTRIF
afatinib dimaleate
TABLET;ORAL 201292 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0138 0597-0138-30 1 BOTTLE in 1 CARTON (0597-0138-30) > 30 TABLET, FILM COATED in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Jul 12, 2013TE:RLD:Yes
Patent:8,426,586Patent Expiration:Oct 10, 2029Product Flag?Substance Flag?YDelist Request?
Patent:8,545,884Patent Expiration:Dec 19, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:9,539,258Patent Expiration:Nov 9, 2026Product Flag?Substance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Chubb
Harvard Business School
Moodys
Novartis
AstraZeneca
Queensland Health
Merck
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot